Works by Wang, Xiaoxin X.


Results: 8
    1
    2

    Early PQQ supplementation has persistent long-term protective effects on developmental programming of hepatic lipotoxicity and inflammation in obese mice.

    Published in:
    FASEB Journal, 2017, v. 31, n. 4, p. 1434, doi. 10.1096/fj.201600906R
    By:
    • Jonscher, Karen R.;
    • Stewart, Michael S.;
    • Alfonso-Garcia, Alba;
    • DeFelice, Brian C.;
    • Wang, Xiaoxin X.;
    • Yuhuan Luo;
    • Levi, Moshe;
    • Heerwagen, Margaret J. R.;
    • Janssen, Rachel C.;
    • de la Houssaye, Becky A.;
    • Wiitala, Ellen;
    • Florey, Garrett;
    • Jonscher, Raleigh L.;
    • Potma, Eric O.;
    • Fiehn, Oliver;
    • Friedman, Jacob E.
    Publication type:
    Article
    3
    4
    5
    6

    Diabetic Nephropathy Is Accelerated by Farnesoid X Receptor Deficiency and Inhibited by Farnesoid X Receptor Activation in a Type 1 Diabetes Model.

    Published in:
    Diabetes, 2010, v. 59, n. 11, p. 2916, doi. 10.2337/db10-0019
    By:
    • Wang, Xiaoxin X.;
    • Jiang, Tao;
    • Shen, Yan;
    • Caldas, Yupanqui;
    • Miyazaki-Anzai, Shinobu;
    • Santamaria, Hannah;
    • Urbanek, Cydney;
    • Solis, Nathaniel;
    • Scherzer, Pnina;
    • Lewis, Linda;
    • Gonzalez, Frank J.;
    • Adorini, Luciano;
    • Pruzanski, Mark;
    • Kopp, Jeffrey B.;
    • Verlander, Jill W.;
    • Levi, Moshe
    Publication type:
    Article
    7

    Farnesoid X Receptor Modulates Renal Lipid Metabolism, Fibrosis, and Diabetic Nephropathy.

    Published in:
    Diabetes, 2007, v. 56, n. 10, p. 2485, doi. 10.2337/db06-1642
    By:
    • Tao Jiang;
    • Wang, Xiaoxin X.;
    • Scherzer, Pnina;
    • Wilson, Paul;
    • Tallman, James;
    • Takahashi, Hideaki;
    • Jinping Li;
    • Division of Renal Diseases and Hypertension, Departments of Medicine, Physiology and Biophysics, Denver VA;
    • Iwahashi, Mieko;
    • Sutherland, Eileen;
    • Arend, Lois;
    • Levi, Moshe
    Publication type:
    Article
    8